Intestinal goblet cell defect is linked to immune dysregulation in multiple sclerosis

Modifications of the gut environment including dysbiosis, immune dysregulation, and impaired barrier integrity have been documented in multiple sclerosis (MS). The mucus layer is an important component of the gut barrier that regulates host-microbiota interactions. Mucus-secreting goblet cells and mucus-associated immune pathways are crucial to promote tolerance and regulatory T-cell differentiation, thus maintaining immune homeostasis in the gut but also in extra-intestinal tissues such as the central nervous system (CNS). Here we investigated the integrity of the mucus layer and mucus-associated immune regulatory pathways in multiple sclerosis patients. We analyzed the integrity of the duodenal mucus layer and its association with microbiota composition and immune regulation in intestinal biopsies and fecal samples from multiple sclerosis patients and healthy controls. Duodenal biopsies and fecal samples were analyzed using histology, flow cytometry, qPCR, and fecal metagenomic whole-genome sequencing. Multiple sclerosis patients have evidence of goblet cell dysfunction measured as a significant reduction of Alcian Blue-positive and UEA-1-positive goblet cells in intestinal crypts. Fecal metagenomic analysis was associated with higher relative abundance of species with reported mucin-degrading capacity, including A. muciniphila , (A) glycaniphila , (B) cellulosilyticus , and P. coprophilus . Further, there was reduced relative abundance of species reported to support goblet cell differentiation and maturation, such as B. breve and (C) butyricum . Immunophenotyping demonstrated a reduction of intestinal FoxP3-positive regulatory T cells. In EAE-immunized mice, enzymatic disruption of the mucus barrier worsened CNS autoimmunity, supporting a functional link between mucus barrier integrity and neuroinflammation. These data indicate that mucus barrier integrity is associated with regulation of CNS autoimmunity and suggest that restoring mucus integrity may represent a therapeutic strategy in MS. The intestine is protected by a mucus layer that helps keep gut bacteria separated from the body and supports balanced immune responses. In multiple sclerosis, changes in the gut environment influence immune cells that attack the brain and spinal cord. We studied intestinal samples, stool bacteria, and immune cells from people with multiple sclerosis and healthy individuals. People with multiple sclerosis had evidence of goblet cell dysfunction, and lower abundance of bacterial species reported to sustain mucus regeneration, and reduced intestinal differentiation of regulatory T cells that are essential to prevent autoimmune attack of the brain. In a mouse model of multiple sclerosis, damaging the mucus layer made disease worse. These findings suggest that protecting or restoring the intestinal mucus barrier integrity may help support immune balance and prevent disease relapses in multiple sclerosis.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-77533-2
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Intestinal goblet cell defect is linked to immune dysregulation in multiple sclerosis

Federica Ungaro, Vittorio Martinelli, Vittoria Palmieri, Francesco Asnicar et al.
Scientific Reports
Gut microbiota and health
article

Intestinal goblet cell defect is linked to immune dysregulation in multiple sclerosis

Federica Ungaro, Vittorio Martinelli, Vittoria Palmieri, Francesco Asnicar, Martina Antonini Cencicchio, Federico Montini, Nicola Segata, Marika Falcone, Luca Massimino, Howard L. Weiner, Luke A. Schwerdtfeger, Sofia Zoe Tonino
article en

Abstract

Modifications of the gut environment including dysbiosis, immune dysregulation, and impaired barrier integrity have been documented in multiple sclerosis (MS). The mucus layer is an important component of the gut barrier that regulates host-microbiota interactions. Mucus-secreting goblet cells and mucus-associated immune pathways are crucial to promote tolerance and regulatory T-cell differentiation, thus maintaining immune homeostasis in the gut but also in extra-intestinal tissues such as the central nervous system (CNS). Here we investigated the integrity of the mucus layer and mucus-associated immune regulatory pathways in multiple sclerosis patients. We analyzed the integrity of the duodenal mucus layer and its association with microbiota composition and immune regulation in intestinal biopsies and fecal samples from multiple sclerosis patients and healthy controls. Duodenal biopsies and fecal samples were analyzed using histology, flow cytometry, qPCR, and fecal metagenomic whole-genome sequencing. Multiple sclerosis patients have evidence of goblet cell dysfunction measured as a significant reduction of Alcian Blue-positive and UEA-1-positive goblet cells in intestinal crypts. Fecal metagenomic analysis was associated with higher relative abundance of species with reported mucin-degrading capacity, including A. muciniphila , (A) glycaniphila , (B) cellulosilyticus , and P. coprophilus . Further, there was reduced relative abundance of species reported to support goblet cell differentiation and maturation, such as B. breve and (C) butyricum . Immunophenotyping demonstrated a reduction of intestinal FoxP3-positive regulatory T cells. In EAE-immunized mice, enzymatic disruption of the mucus barrier worsened CNS autoimmunity, supporting a functional link between mucus barrier integrity and neuroinflammation. These data indicate that mucus barrier integrity is associated with regulation of CNS autoimmunity and suggest that restoring mucus integrity may represent a therapeutic strategy in MS. The intestine is protected by a mucus layer that helps keep gut bacteria separated from the body and supports balanced immune responses. In multiple sclerosis, changes in the gut environment influence immune cells that attack the brain and spinal cord. We studied intestinal samples, stool bacteria, and immune cells from people with multiple sclerosis and healthy individuals. People with multiple sclerosis had evidence of goblet cell dysfunction, and lower abundance of bacterial species reported to sustain mucus regeneration, and reduced intestinal differentiation of regulatory T cells that are essential to prevent autoimmune attack of the brain. In a mouse model of multiple sclerosis, damaging the mucus layer made disease worse. These findings suggest that protecting or restoring the intestinal mucus barrier integrity may help support immune balance and prevent disease relapses in multiple sclerosis.

Scientific Reports
Brigham and Women's Hospital (US), Harvard University (US), Vita-Salute San Raffaele University (IT), University of Trento (IT), IRCCS Ospedale San Raffaele (IT), Colorado State University (US)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon